First Header Logo Second Header Logo

Christina Cramer

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
16
2019
587
3.010
 Why?
Radiosurgery
11
2019
322
1.720
 Why?
Radiotherapy
1
2019
74
0.670
 Why?
Hypoglycemic Agents
1
2018
175
0.610
 Why?
Urinary Bladder Neoplasms
1
2018
179
0.540
 Why?
Treatment Outcome
10
2019
3099
0.460
 Why?
Retrospective Studies
13
2019
3107
0.450
 Why?
Cranial Irradiation
5
2019
84
0.430
 Why?
Aged
16
2019
9462
0.430
 Why?
Middle Aged
17
2019
10805
0.420
 Why?
Aged, 80 and over
9
2019
3712
0.390
 Why?
Neuropsychological Tests
3
2019
378
0.390
 Why?
Neoplasm Recurrence, Local
3
2018
337
0.370
 Why?
Olfaction Disorders
1
2009
6
0.360
 Why?
Affective Symptoms
1
2009
16
0.360
 Why?
Salvage Therapy
3
2018
118
0.340
 Why?
Parkinson Disease
1
2009
68
0.340
 Why?
Male
17
2019
17768
0.330
 Why?
Female
17
2019
18114
0.330
 Why?
Radiotherapy, Conformal
2
2018
19
0.330
 Why?
Humans
19
2019
29013
0.300
 Why?
Follow-Up Studies
4
2018
2106
0.280
 Why?
Lung Neoplasms
3
2019
384
0.270
 Why?
Prognosis
6
2018
1362
0.270
 Why?
Adult
9
2019
8391
0.260
 Why?
Survival Rate
4
2018
795
0.240
 Why?
Neoplasm Metastasis
2
2019
199
0.190
 Why?
Radiotherapy, Adjuvant
2
2017
68
0.190
 Why?
Trigeminal Neuralgia
1
2019
33
0.180
 Why?
Small Cell Lung Carcinoma
1
2019
14
0.180
 Why?
Melanoma
2
2017
148
0.170
 Why?
Disease Susceptibility
1
2019
53
0.170
 Why?
Prospective Studies
3
2019
2010
0.170
 Why?
Multiple Sclerosis
1
2019
43
0.170
 Why?
Maximum Tolerated Dose
1
2018
56
0.170
 Why?
Costs and Cost Analysis
1
2018
88
0.160
 Why?
Lymphatic Metastasis
1
2018
156
0.160
 Why?
Genomics
1
2018
82
0.160
 Why?
Medicare
1
2018
185
0.150
 Why?
Meningeal Neoplasms
1
2017
46
0.150
 Why?
Meningioma
1
2017
51
0.150
 Why?
Survivors
1
2018
145
0.150
 Why?
Glioblastoma
1
2018
143
0.150
 Why?
Quality of Life
2
2019
815
0.150
 Why?
Hippocampus
1
2017
185
0.140
 Why?
Retroperitoneal Neoplasms
1
2015
11
0.130
 Why?
Sarcoma
1
2015
56
0.130
 Why?
Adenocarcinoma
1
2017
301
0.120
 Why?
Smoking
1
2017
427
0.120
 Why?
Disease Progression
3
2019
572
0.110
 Why?
Young Adult
1
2018
2398
0.100
 Why?
Neoplasms
1
2018
608
0.100
 Why?
Psychiatric Status Rating Scales
1
2009
92
0.090
 Why?
Smell
1
2009
46
0.090
 Why?
Disease-Free Survival
2
2017
281
0.070
 Why?
Combined Modality Therapy
2
2018
524
0.070
 Why?
Radiation Dosage
1
2019
72
0.040
 Why?
Postoperative Period
1
2018
91
0.040
 Why?
Disease Management
1
2019
114
0.040
 Why?
Rats, Wistar
1
2017
84
0.040
 Why?
Radiometry
1
2017
39
0.040
 Why?
Radiotherapy Planning, Computer-Assisted
1
2017
28
0.040
 Why?
Brain Death
1
2017
27
0.040
 Why?
Clinical Trials as Topic
1
2019
298
0.040
 Why?
Confidence Intervals
1
2017
140
0.040
 Why?
Incidence
1
2019
1105
0.030
 Why?
Survival Analysis
1
2017
440
0.030
 Why?
Analysis of Variance
1
2017
454
0.030
 Why?
Carcinoma, Renal Cell
1
2017
109
0.030
 Why?
Cohort Studies
1
2019
1674
0.030
 Why?
Perioperative Care
1
2015
58
0.030
 Why?
Kidney Neoplasms
1
2017
192
0.030
 Why?
Rats
1
2017
1604
0.030
 Why?
Time Factors
1
2017
1997
0.030
 Why?
Breast Neoplasms
1
2017
666
0.020
 Why?
United States
1
2018
3604
0.020
 Why?
Risk Factors
1
2017
3509
0.020
 Why?
Animals
1
2017
7297
0.020
 Why?
Cramer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (23)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_